Last 20 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Astrana Health, Inc.'s quarterly P/E stands at 21.1x, down 61.8% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has compressed 34.7% YoY to 10.2x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 86.07 | 21.14 | 51.69 | 945.00 | 32.74 | 55.38 | — | 43.89 | 25.35 | 33.86 | 36.83 | 16.41 | 28.21 |
| — | -61.8% | — | +2052.9% | +29.1% | +63.5% | — | +167.5% | -10.2% | +4.0% | — | -5.8% | -26.9% | |
| P/S Ratio | 0.62 | 0.31 | 0.32 | 0.37 | 0.47 | 0.61 | 0.57 | 1.46 | 1.00 | 1.24 | 1.29 | 1.04 | 1.06 |
| — | -49.0% | -43.1% | -74.9% | -53.0% | -50.9% | -55.9% | +40.4% | -5.7% | -2.1% | +10.1% | -26.8% | -35.5% | |
| P/B Ratio | 3.50 | 2.08 | 2.20 | 2.53 | 2.29 | 2.93 | 2.94 | 5.51 | 4.07 | 4.44 | 4.43 | 2.35 | 2.53 |
| — | -28.8% | -25.1% | -54.1% | -43.7% | -34.1% | -33.7% | +134.3% | +60.5% | +49.9% | +79.6% | -27.7% | -25.0% | |
| P/FCF | 18.79 | 4.69 | — | 47.36 | 3.44 | 27.93 | — | 22.05 | 23.90 | 89.58 | 37.17 | 32.02 | 15.87 |
| — | -83.2% | — | +114.8% | -85.6% | -68.8% | — | -31.2% | +50.6% | — | +806.7% | — | -72.6% | |
| EV / EBITDA | 21.02 | 10.17 | 13.49 | 14.56 | 12.28 | 15.56 | 47.89 | 20.47 | 13.97 | 14.96 | 447.51 | 8.12 | 11.31 |
| — | -34.7% | -71.8% | -28.8% | -12.1% | +4.0% | -89.3% | +152.1% | +23.6% | -4.3% | +2157.8% | -3.1% | -49.4% | |
| EV / EBIT | 33.26 | 15.68 | 25.52 | 21.67 | 13.83 | 25.24 | 68.62 | 20.48 | 12.94 | 16.68 | 72.78 | 8.43 | 10.07 |
| — | -37.9% | -62.8% | +5.8% | +6.8% | +51.3% | -5.7% | +143.0% | +28.6% | -9.2% | +187.4% | -19.9% | -57.8% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Astrana Health, Inc.'s operating margin was 3.0% in Q1 2026, up 1.0 pp QoQ and down 0.4 pp YoY. Gross margin contracted 18.7% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 9.3% | 9.4% | 8.3% | 8.5% | 11.9% | 11.5% | 9.5% | 15.4% | 13.6% | 17.0% | 11.0% | 20.9% | 15.9% |
| — | -18.7% | -12.7% | -44.4% | -12.3% | -32.5% | -14.2% | -26.6% | -14.6% | +20.0% | -20.9% | -13.1% | +8.2% | |
| Operating Margin | 2.5% | 3.0% | 1.9% | 2.0% | 3.1% | 3.3% | 0.1% | 5.9% | 6.2% | 7.5% | -1.1% | 11.2% | 7.8% |
| — | -10.9% | +1688.5% | -66.2% | -49.8% | -55.5% | +109.9% | -47.1% | -20.3% | +12.4% | -125.6% | -29.0% | +36.1% | |
| Net Margin | 0.7% | 1.5% | 0.6% | 0.0% | 1.4% | 1.1% | -1.0% | 3.4% | 3.9% | 3.7% | 3.5% | 6.3% | 3.8% |
| — | +38.7% | +160.4% | -98.8% | -63.5% | -70.6% | -129.9% | -46.9% | +4.2% | -5.8% | +496.1% | -13.4% | -14.6% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 4.2% | 2.5% | 1.1% | 0.1% | 1.8% | 1.3% | -1.4% | 3.3% | 4.1% | 3.4% | 2.4% | 3.7% | 2.3% |
| — | +96.0% | +179.2% | -97.9% | -56.6% | -62.3% | -156.5% | -11.2% | +81.6% | +48.7% | +614.8% | -14.4% | +0.3% | |
| ROA | 1.3% | 0.6% | 0.3% | 0.0% | 0.7% | 0.5% | -0.5% | 1.3% | 1.5% | 1.4% | 1.2% | 2.1% | 1.3% |
| — | +26.6% | +151.1% | -98.4% | -56.1% | -63.7% | -142.8% | -39.6% | +18.6% | +2.5% | +552.3% | -14.2% | +1.7% | |
| ROIC | 6.2% | 1.8% | 1.2% | 1.6% | 2.2% | 2.2% | 0.1% | 3.4% | 3.8% | 4.6% | -0.6% | 5.3% | 3.9% |
| — | -17.7% | +1325.5% | -53.2% | -41.1% | -52.0% | +114.2% | -36.9% | -0.8% | +40.5% | -133.1% | -21.3% | +68.7% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Astrana Health, Inc.'s Debt/EBITDA ratio is 24.2x, down from 31.0x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 20.6% YoY to 1.35x, tightening the short-term liquidity position. Debt/Equity has declined for 3 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.93 | 1.84 | 1.93 | 1.96 | 0.83 | 0.87 | 0.92 | 0.94 | 0.99 | 0.96 | 0.78 | 0.38 | 0.39 |
| — | +111.6% | +110.4% | +108.9% | -16.2% | -9.0% | +17.4% | +145.2% | +151.7% | +142.2% | +90.3% | -5.1% | -7.0% | |
| Debt / EBITDA | 8.68 | 24.21 | 30.98 | 31.24 | 16.43 | 16.45 | 53.34 | 13.33 | 12.68 | 12.31 | 311.06 | 5.43 | 7.36 |
| — | +47.1% | -41.9% | +134.3% | +29.6% | +33.7% | -82.9% | +145.5% | +72.1% | +43.5% | +2157.1% | +33.5% | -34.9% | |
| Current Ratio | 1.40 | 1.35 | 1.40 | 1.40 | 1.59 | 1.70 | 1.75 | 1.91 | 1.84 | 1.51 | 2.11 | 2.35 | 2.50 |
| — | -20.6% | -19.7% | -26.5% | -13.7% | +12.3% | -17.3% | -18.7% | -26.6% | -45.1% | -26.7% | -17.4% | +0.6% | |
| Quick Ratio | 1.40 | 1.35 | 1.40 | 1.40 | 1.59 | 1.70 | 1.75 | 1.91 | 1.84 | 1.51 | 2.11 | 2.35 | 2.50 |
| — | -20.6% | -19.7% | -26.5% | -13.7% | +12.3% | -17.3% | -18.7% | -26.6% | -45.1% | -26.7% | -17.4% | +0.6% | |
| Interest Coverage | 1.57 | 1.77 | 1.05 | 1.32 | 3.28 | 2.31 | 0.77 | 4.03 | 4.71 | 4.16 | 1.17 | 11.06 | 9.67 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 20 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ASTH stock.
Astrana Health, Inc.'s current P/E is 86.1x. The average P/E over the last 4 quarters is 262.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Astrana Health, Inc.'s current operating margin is 2.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Astrana Health, Inc.'s business trajectory between earnings reports.